Kuwait Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
October 22, 2014
122 Pages - SKU: BMI5361535
Countries covered: Kuwait

Kuwait Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Notwithstanding a recent escalation in political uncertainty, Kuwait's healthcare sector isforecast to preserve its trajectory of modest growth throughout the remainder of 2014. Rising sales areunderpinned by an expanding population, whose levels of chronic conditions increasingly call for thesupply of long-term treatments and cutting-edge medical equipment. In addition, apprehension towards fakegenerics and an accompanying government crackdown have further solidified popular demand for brandeddrugs. However, a confusing bureaucracy and sluggish implementation of key foreign direct investment andintellectual property reform will continue to dampen overall investment and restrain Kuwait from matchingthe pace of other emerging economies.

Headline Expenditure Projections

Pharmaceuticals: KWD290mn (USD1.02bn) in 2013 to KWD306mn (USD1.10bn) in 2014; +5.6% inlocal currency terms and +7.6% in US dollar terms. Forecast unchanged from Q3 2014.

Healthcare: KWD1.43bn (USD5.03bn) in 2013 to KWD1.56bn (USD5.58bn) in 2014; +8.8% in localcurrency terms and +10.8% in US dollar terms. Forecast unchanged from Q3 2014.



More Prescription Drugs reports by Business Monitor International

Venezuela Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q4 2014BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports frompolitical allies and the potential expansion of free medicine ...
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescriptionnumbers, does not come ...
Switzerland Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q4 2014BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of ...
Qatar Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Qatar Pharmaceuticals and Healthcare Report Q4 2014BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental topharmaceutical ...
See all reports like this >>

More Kuwait Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Kuwait - Q3 2014 by Business Monitor International
Kuwait Pharmaceuticals and Healthcare Report Q3 2014BMI View: Despite upcoming by-elections, Kuwait's economy is forecast to post moderate growth in 2014,and the prospects for consumption ...
KUWAIT Healthcare & Pharmaceuticals 2013 by Noozz Research
KUWAIT Healthcare & Pharmaceuticals 2013Kuwait’s healthcare and pharmaceutical industries, which are dominated by high levels of government expenditure, and a robust, free public healthcare service ...
See all reports like this >>

More Kuwait reports

D&B Country Report: Kuwait by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!